Sandra - Factor, M.F.T, Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1611 Peninsula Dr, Suite E, Manila, CA 95521 Phone: 707-616-7428 Fax: 707-677-3241 |
News Archive
In an article published in the March issue of the Journal of Cardiovascular Pharmacology and Therapeutics, researchers from Florida Atlantic University (FAU) assess the totality of evidence, including strengths and limitations of different types of evidence contributing to the debate about cardiovascular disease (CVD) risks of cyclooxygenase-2 (COX-2) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs).
Young, single women in urban China are aware of contraceptive methods but some may be too shy to ask for them, research published in the online open access journal BMC Health Services Research reveals.
Pfizer Inc. announced today that the U.S. Food and Drug Administration's (FDA) Antiviral Drugs Advisory Committee voted (10 to 4) to recommend the approval of Selzentry (maraviroc) tablets for use in treatment-naïve adult patients with CCR5-tropic HIV-1 virus as part of combination therapy.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
› Verified 9 days ago